A gigapixel camera that takes high-resolution snapshots of the entire body could prove to be a new tool for whole-body skin cancer screening.
Targeting BRAF V600E/K mutation-positive melanoma with dabrafenib in combination with trametinib achieves longer overall survival and impoved response rates, compared to treatment with vemurafenib alone.
The monoclonal antibody nivolumab has demonstrated superior response and duration over standard chemotherapy in patients whose melanoma has progressed after ipilimumab treatment.
A combination of exercise with chemotherapy shrunk tumors more than employing chemotherapy alone, according to research performed with a melanoma model.
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieved superior results over vemurafenib plus placebo for BRAF-mutation positive melanoma.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|